Quantcast

Latest Immunosuppressive drug Stories

2010-01-29 14:24:22

Test could lead to tailored treatment for patients at highest risk Measuring certain types of immune cells may predict the high risk of skin cancer after kidney transplantation, according to a study appearing in an upcoming issue of the Journal of the American Society Nephrology (JASN). "There are differences in the immune system, and some of these are associated with the development of skin cancer after transplantation," comments Robert Carroll, MD (The Queen Elizabeth Hospital, Woodville,...

2009-12-15 13:53:00

WASHINGTON, Dec. 15 /PRNewswire-USNewswire/ -- Today's New York Times article by Kevin Sack, "Plan for Kidney Drugs Spurs Division," illustrates an internal renal community reimbursement debate that may result in kidney patients continuing to be deprived of their life-saving immunosuppressive medications beyond the current 36-month Medicare program limit. As Congress is poised to approve this urgent transplant patient coverage to preserve the lives of transplant kidney recipients,...

2009-11-23 15:36:54

People need longer-term support than most friends, relatives or health care professionals realize People who have kidney transplants need longer-term support than most friends, relatives or even healthcare professionals realise, according to a study of 160 patients published in the December issue of the UK-based Journal of Advanced Nursing. Researchers surveyed 55 patients who had undergone surgery in the last year, together with 105 who had had surgery in the last one to three years at the...

2009-11-01 06:19:03

Treatment reduces risk, but nearly half of patients stop treatment due to side effects Switching to a newer type of immunosuppressant drug may reduce the high rate of skin cancer after kidney transplantation, according to research presented at the American Society of Nephrology's 42nd Annual Meeting and Scientific Exposition in San Diego, CA. "In spite of the life-saving nature of organ transplantation, the need for transplant recipients to continue treatment with drugs that suppress the...

2009-10-29 14:32:48

Overall cancer risk comparable to those not taking immunosuppressive drugs A recent study by Swedish researchers found that rheumatoid arthritis (RA) patients did not experience an elevated cancer risk in the first 6 years after starting anti-tumor necrosis factor (TNF) therapy. The research team, led by Johan Askling, M.D., Ph.D., from Karolinska University Hospital in Stockholm, Sweden assessed the short-term and medium-term cancer risk for RA patients using anti-TNF therapies: infliximab,...

2009-10-26 22:53:59

Findings from a new retrospective cohort study presented at the American College of Gastroenterology's 74th Annual Scientific meeting in San Diego indicate that patients with Inflammatory Bowel Disease (IBD), especially those receiving the thiopurine class of medications to treat IBD, may be at risk for developing non-melanoma skin cancer (NMSC). Dr. Millie Long, of the University of North Carolina, Chapel Hill, and her colleagues examined the records of 26,403 patients with Crohn's disease...

2009-10-08 15:23:00

AST Delivers Letter to Senate Leadership WASHINGTON, Oct. 8 /PRNewswire-USNewswire/ -- As the Senate Finance Committee prepares to vote on the amended health care reform package, members of the American Society of Transplantation (AST) arrived on Capitol Hill armed with a letter encouraging the Senate to adopt a health care provision that will extend Medicare's coverage of post-transplant drugs, which are critical to maintaining the health of the transplant patient. Immunosuppressive...

2009-10-08 11:53:00

WASHINGTON, Oct. 8 /PRNewswire/ -- As Congress wraps up work on health care reform, members of the American Society of Transplantation's (AST) Public Policy Committee arrived on Capitol Hill today to discuss the importance of supporting a health care provision that would ensure kidney transplant recipients continue to receive Medicare coverage for immunosuppressive drugs. The Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act of 2009, in the health care reform...

2009-10-05 10:56:55

Data from the largest single-center experience of adult and pediatric intestinal and multivisceral transplantation show that survival rates have improved with the advent of innovative surgical techniques, novel immunosuppressive protocols and better post-operative management, said researchers at the Thomas E. Starzl Transplantation Institute in a study published in the October issue of Annals of Surgery. Led by Kareem Abu-Elmagd, M.D., Ph.D., director, Intestinal Rehabilitation and...

2009-09-03 12:22:00

NEW YORK, Sept. 3 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue. Liver Disease Treatments: The Global Market http://www.reportlinker.com/p0128142/Liver-Disease-Treatments-The-Global-Market.html This Report: Provides an overview of the global market for liver disease treatments, with market forecasts through 2014 Classifies therapies based on diseases including virus-induced liver disease/Hepatitis, liver tumors, autoimmune...


Word of the Day
drawcansir
  • A blustering, bullying fellow; a pot-valiant braggart; a bully.
This word is named for Draw-Can-Sir, a character in George Villiers' 17th century play The Rehearsal.
Related